Q1 2014 13F Holders as of 31 Mar 2014
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Number of holders
-
77
-
Total 13F shares, excl. options
-
15,678,184
-
Shares change
-
+15,678,184
-
Total reported value, excl. options
-
$746,820,000
-
Value change
-
+$746,820,000
-
Number of buys
-
77
-
Price
-
$48.89
Institutional Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q1 2014
As of 31 Mar 2014 Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) had 77 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 15,678,184 shares of stock of the company.
Largest 10 holders included TPG Group Holdings (SBS) Advisors, Inc., Capital Research Global Investors, ADAGE CAPITAL PARTNERS GP LLC, COLUMBIA WANGER ASSET MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT CO LLP, Visium Asset Management, LP, Capital World Investors, FMR LLC, and JENNISON ASSOCIATES LLC.
This table shows 77 institutional shareholders of the security as of 31 Mar 2014.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.